0,860  0,010  Apoptosis agonist
0,853  0,010  Transcription factor NF kappa B inhibitor
0,788  0,017  Antiinflammatory
0,772  0,004  Cardiotonic
0,740  0,015  CYP3A4 substrate
0,733  0,009  Respiratory analeptic
0,720  0,002  Contraceptive
0,707  0,017  Antineoplastic (lung cancer)
0,686  0,002  Postmenopausal disorders treatment
0,693  0,010  Chemopreventive
0,687  0,010  Antineoplastic (ovarian cancer)
0,692  0,017  Teratogen
0,658  0,008  NOS3 expression inhibitor
0,660  0,010  Sensitization
0,665  0,025  Antineoplastic (breast cancer)
0,631  0,005  Heart failure treatment
0,644  0,019  Embryotoxic
0,614  0,013  Bone diseases treatment
0,616  0,022  Antineoplastic (colorectal cancer)
0,603  0,017  Carcinogenic
0,593  0,014  Analeptic
0,576  0,002  Mineralocorticoid receptor antagonist
0,584  0,013  Proliferative diseases treatment
0,586  0,023  Antineoplastic (colon cancer)
0,580  0,020  Prostate cancer treatment
0,581  0,023  CYP2C9 substrate
0,542  0,019  Cytotoxic
0,537  0,016  Antiosteoporotic
0,533  0,019  Antineoplastic (cervical cancer)
0,533  0,020  Antineoplastic (melanoma)
0,507  0,004  Abortion inducer
0,507  0,010  UGT1A1 substrate
0,529  0,035  Antileukemic
0,493  0,004  Lipocortins synthesis antagonist
0,496  0,008  Diuretic
0,481  0,017  Nitric oxide antagonist
0,470  0,016  Antineoplastic (lymphoma)
0,468  0,025  Antineoplastic (pancreatic cancer)
0,454  0,011  Antineoplastic (sarcoma)
0,440  0,006  Antipruritic, non-allergic
0,434  0,009  Prostate disorders treatment
0,443  0,021  Hypoxia-inducible factor 1 alpha inhibitor
0,438  0,022  UGT2B4 substrate
0,457  0,045  Immunosuppressant
0,434  0,026  NOS2 expression inhibitor
0,445  0,041  Cholesterol antagonist
0,460  0,058  TNF expression inhibitor
0,412  0,019  UDP-glucuronosyltransferase substrate
0,396  0,005  Androgen antagonist
0,404  0,015  UGT1A4 substrate
0,394  0,008  Interleukin 6 antagonist
0,384  0,013  Antiacne
0,408  0,038  Antihypertensive
0,404  0,039  AR expression inhibitor
0,382  0,023  Sodium/bile acid cotransporter inhibitor
0,389  0,032  Antiprotozoal (Leishmania)
0,358  0,003  Progesterone antagonist
0,396  0,042  ICAM1 expression inhibitor
0,376  0,028  UGT1A6 substrate
0,346  0,006  UGT2B9 substrate
0,385  0,047  CYP2D6 substrate
0,343  0,005  Contraceptive male
0,353  0,016  Prostatic (benign) hyperplasia treatment
0,351  0,015  Anesthetic
0,378  0,044  CYP1A2 substrate
0,377  0,045  Antineoplastic (brain cancer)
0,373  0,041  Antineoplastic (glioma)
0,330  0,005  Estrogen agonist
0,341  0,020  Antiviral (Influenza)
0,347  0,034  Antineoplastic (liver cancer)
0,327  0,021  UGT2B7 substrate
0,295  0,001  Na+ K+ transporting ATPase inhibitor
0,312  0,027  P-glycoprotein inhibitor
0,300  0,016  Antiviral (Influenza A)
0,276  0,003  Premenstrual syndrome treatment
0,349  0,091  Antipruritic, allergic
0,269  0,017  Antidiabetic (type 1)
0,320  0,072  Apoptosis antagonist
0,282  0,036  Growth hormone agonist
0,261  0,024  UGT2B15 substrate
0,341  0,107  Antibacterial
0,240  0,008  Arachidonic acid antagonist
0,304  0,076  CYP3A4 inhibitor
0,243  0,015  UGT2B10 substrate
0,304  0,080  Hepatic disorders treatment
0,291  0,071  CYP2C19 substrate
0,238  0,020  Antifungal enhancer
0,267  0,050  Mutagenic
0,271  0,056  Antineoplastic (glioblastoma multiforme)
0,278  0,063  Antineoplastic (renal cancer)
0,234  0,021  Adenylate cyclase inhibitor
0,216  0,004  Estrogen receptor alpha agonist
0,295  0,083  Antineoplastic (endocrine cancer)
0,274  0,067  Transcription factor STAT3 inhibitor
0,236  0,031  Interferon gamma antagonist
0,286  0,083  Antipsoriatic
0,268  0,070  Antineoplastic (non-small cell lung cancer)
0,238  0,047  Hepatoprotectant
0,263  0,074  Chemoprotective
0,191  0,002  Progesterone agonist
0,192  0,005  Estrogen receptor beta agonist
0,224  0,036  Antineoplastic (squamous cell carcinoma)
0,215  0,029  Antidiarrheal
0,191  0,005  Androgen agonist
0,197  0,013  Estrogen antagonist
0,187  0,006  Anabolic
0,272  0,095  Antifungal
0,190  0,016  Contraceptive female
0,195  0,021  Microtubule formation inhibitor
0,216  0,043  UGT1A3 substrate
0,187  0,015  Pregnane X receptor agonist
0,177  0,007  UGT2B11 substrate
0,331  0,162  Caspase 9 stimulant
0,246  0,079  Vascular (periferal) disease treatment
0,207  0,042  Antineoplastic (carcinoma)
0,204  0,040  Toxic, respiratory center
0,188  0,025  Antifungal (Cryptococcus)
0,172  0,010  SULT1E1 substrate
0,179  0,026  Adenylate cyclase stimulant
0,268  0,126  Calcium channel activator
0,205  0,069  Pneumotoxic
0,163  0,027  Alcohol dehydrogenase substrate
0,165  0,029  Endometrios treatment
0,161  0,028  Anticataract
0,140  0,019  Estrogen receptor beta antagonist
0,234  0,113  Antihypoxic
0,144  0,024  Toll-Like receptor 4 antagonist
0,134  0,015  Aromatase inhibitor
0,148  0,034  Choleretic
0,143  0,032  Antineoplastic antibiotic
0,122  0,012  Glycine receptor agonist
0,179  0,069  Muscle relaxant
0,240  0,130  Interleukin 2 agonist
0,222  0,113  Cardioprotectant
0,154  0,048  Farnesoid X receptor antagonist
0,192  0,089  Antimitotic
0,112  0,009  Hypercalcemia treatment
0,146  0,047  Cholesterol synthesis inhibitor
0,145  0,049  Antiviral (Hepatitis B)
0,169  0,072  ATPase inhibitor
0,102  0,009  Opioid kappa receptor agonist
0,098  0,006  Lipocortins synthesis agonist
0,178  0,088  Anesthetic general
0,201  0,113  Antioxidant
0,189  0,100  Angiogenesis stimulant
0,092  0,004  Parathyroid hormone antagonist
0,145  0,057  Carcinogenic, group 3
0,187  0,099  Antineoplastic enhancer
0,093  0,007  RNA-directed RNA polymerase stimulant
0,165  0,080  Phospholipase C inhibitor
0,193  0,109  Antihypercholesterolemic
0,227  0,147  Antithrombotic
0,207  0,128  Transcription factor STAT inhibitor
0,123  0,045  UGT2B1 substrate
0,114  0,035  Actinic keratosis treatment
0,112  0,037  ABCA1 expression enhancer
0,131  0,058  Growth stimulant
0,120  0,047  Antiinfertility, female
0,150  0,078  Antiviral (Herpes)
0,083  0,012  Postcoital contraceptive
0,093  0,022  Anticholelithogenic
0,187  0,117  Peptidyltransferase inhibitor
0,216  0,147  Caspase 3 stimulant
0,148  0,084  Melanin inhibitor
0,095  0,030  Estrogen receptor alpha antagonist
0,071  0,006  Microtubule stabilization
0,093  0,030  Narcotic antagonist
0,083  0,021  SULT2A1 substrate
0,074  0,014  Potassium channel Kv1.3 blocker
0,064  0,005  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,095  0,037  Glycine receptor antagonist
0,142  0,086  Urolithiasis treatment
0,097  0,041  Transcription factor NF kappa B stimulant
0,069  0,014  Vanilloid 2 antagonist
0,064  0,010  Glucocorticoid antagonist
0,131  0,079  Psychosexual dysfunction treatment
0,067  0,015  Aldosterone antagonist
0,210  0,158  CTGF expression inhibitor
0,055  0,004  Vitamin D receptor antagonist
0,066  0,017  Anesthetic inhalation
0,097  0,050  Antineoplastic alkaloid
0,070  0,025  Heme oxygenase stimulant
0,050  0,012  Glucose-6-phosphate dehydrogenase inhibitor
0,125  0,088  Protein kinase stimulant
0,069  0,033  Antimycoplasmal
0,054  0,022  Adenylate cyclase 1 inhibitor
0,082  0,055  Opioid kappa receptor antagonist
0,034  0,009  CYP24 inhibitor
0,204  0,181  Antineoplastic (osteosarcoma)
0,037  0,014  Estrogen-related receptor beta antagonist
0,118  0,097  Hair growth stimulant
0,125  0,106  NOS3 expression enhancer
0,073  0,056  SULT1A2 substrate
0,036  0,021  Tubulin agonist
0,070  0,057  CDC25A inhibitor
0,112  0,100  Skin whitener
0,220  0,209  CYP2C19 inhibitor
0,019  0,008  Vitamin D receptor agonist
0,018  0,008  Glucocorticoid agonist
0,036  0,027  5-Alpha-reductase inhibitor
0,067  0,059  Antibiotic
0,035  0,028  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,043  0,036  Opioid mu receptor agonist
0,021  0,015  Corticosteroid-like
0,048  0,042  Opioid agonist
0,069  0,063  Cushing's syndrome treatment
0,033  0,027  HMG CoA reductase inhibitor
0,119  0,114  Eye irritation, high
0,029  0,026  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,085  0,083  Glutathione S-transferase substrate
0,004  0,003  Vitamin D-like
0,011  0,010  3 Beta-hydroxy-delta 5-steroid dehydrogenase inhibitor
0,038  0,038  Hypogonadism treatment

